These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21343396)

  • 21. The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapy.
    Lane J; Martin TA; McGuigan C; Mason MD; Jiang WG
    J Exp Ther Oncol; 2010; 8(3):203-10. PubMed ID: 20734919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human concentrative nucleoside transporter 3 transfection with ultrasound and microbubbles in nucleoside transport deficient HEK293 cells greatly increases gemcitabine uptake.
    Paproski RJ; Yao SY; Favis N; Evans D; Young JD; Cass CE; Zemp RJ
    PLoS One; 2013; 8(2):e56423. PubMed ID: 23441192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer.
    Fan J; Wei Q; Koay EJ; Liu Y; Ning B; Bernard PW; Zhang N; Han H; Katz MH; Zhao Z; Hu Y
    Theranostics; 2018; 8(21):5986-5994. PubMed ID: 30613276
    [No Abstract]   [Full Text] [Related]  

  • 24. The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer.
    Liu B; Yang H; Pilarsky C; Weber GF
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29949874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Claudin 7 as a possible novel molecular target for the treatment of pancreatic cancer.
    Okui N; Kamata Y; Sagawa Y; Kuhara A; Hayashi K; Uwagawa T; Homma S; Yanaga K
    Pancreatology; 2019 Jan; 19(1):88-96. PubMed ID: 30416041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miRNA signatures underlie chemoresistance in the gemcitabine-resistant pancreatic ductal adenocarcinoma cell line MIA PaCa-2 GR.
    Fuller RN; Vallejos PA; Kabagwira J; Liu T; Wang C; Wall NR
    Front Genet; 2024; 15():1393353. PubMed ID: 38919953
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of human nucleoside transporters in pancreatic cancer and chemoresistance.
    Carter CJ; Mekkawy AH; Morris DL
    World J Gastroenterol; 2021 Oct; 27(40):6844-6860. PubMed ID: 34790010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells].
    Sun Y; Jin XL; Zhang TT; Jia CW; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):460-4. PubMed ID: 24246865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
    Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
    Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gatifloxacin induces S and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53.
    Yadav V; Sultana S; Yadav J; Saini N
    PLoS One; 2012; 7(10):e47796. PubMed ID: 23133524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppressive effects of exogenous regucalcin on the proliferation of human pancreatic cancer MIA PaCa-2 cells in vitro.
    Yamaguchi M; Murata T
    Int J Mol Med; 2015 Jun; 35(6):1773-8. PubMed ID: 25847529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors.
    Escorcia FE; Houghton JL; Abdel-Atti D; Pereira PR; Cho A; Gutsche NT; Baidoo KE; Lewis JS
    Theranostics; 2020; 10(1):151-165. PubMed ID: 31903112
    [No Abstract]   [Full Text] [Related]  

  • 33. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
    Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
    Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach.
    Dai H; Li R; Wheeler T; Ozen M; Ittmann M; Anderson M; Wang Y; Rowley D; Younes M; Ayala GE
    Hum Pathol; 2007 Feb; 38(2):299-307. PubMed ID: 17097719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ursolic acid promotes apoptosis, autophagy, and chemosensitivity in gemcitabine-resistant human pancreatic cancer cells.
    Lin JH; Chen SY; Lu CC; Lin JA; Yen GC
    Phytother Res; 2020 Aug; 34(8):2053-2066. PubMed ID: 32185829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines.
    Doi T; Ishikawa T; Okayama T; Oka K; Mizushima K; Yasuda T; Sakamoto N; Katada K; Kamada K; Uchiyama K; Handa O; Takagi T; Naito Y; Itoh Y
    Oncol Rep; 2017 Mar; 37(3):1545-1554. PubMed ID: 28112370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of Hematopoietic Pre-B-cell Leukemia Transcription Factor Interacting Protein Knockdown on Proliferation,Cell Cycle and Apoptosis in Pancreatic Cancer Cells].
    Zhao YM; Yang G; You L; Hu Y; Zhao YP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):7-15. PubMed ID: 32131934
    [No Abstract]   [Full Text] [Related]  

  • 38. Methylation-mediated silencing of TMS1 in pancreatic cancer and its potential contribution to chemosensitivity.
    Ramachandran K; Miller H; Gordian E; Rocha-Lima C; Singal R
    Anticancer Res; 2010 Oct; 30(10):3919-25. PubMed ID: 21036703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of integrin‑linked kinase enhances tumor progression in gemcitabine‑resistant pancreatic cancer.
    Murase H; Matsuo Y; Denda Y; Nonoyama K; Kato T; Aoyama Y; Hayashi Y; Imafuji H; Saito K; Morimoto M; Ogawa R; Takahashi H; Mitsui A; Kimura M; Takiguchi S
    Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37477162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
    Bi YL; Min M; Shen W; Liu Y
    Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.